SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 52 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | -80.0% | 6,038 | +5.9% | 0.00% | – |
| Q2 2019 | $5,000 | -61.5% | 5,700 | 0.0% | 0.00% | – |
| Q1 2019 | $13,000 | -13.3% | 5,700 | -10.9% | 0.00% | – |
| Q4 2018 | $15,000 | -86.6% | 6,400 | -16.0% | 0.00% | – |
| Q3 2018 | $112,000 | -0.9% | 7,622 | +2.6% | 0.00% | – |
| Q2 2018 | $113,000 | +5.6% | 7,430 | +30.2% | 0.00% | – |
| Q1 2018 | $107,000 | +10600.0% | 5,705 | +12865.9% | 0.00% | – |
| Q4 2017 | $1,000 | -87.5% | 44 | -87.6% | 0.00% | – |
| Q3 2017 | $8,000 | – | 354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 758,610 | $1,760,000 | 1.30% |
| Wildcat Capital Management, LLC | 295,613 | $686,000 | 0.45% |
| PFM Health Sciences, LP | 1,576,619 | $3,658,000 | 0.10% |
| Cohen Capital Management, Inc. | 108,010 | $251,000 | 0.07% |
| Partner Investment Management, L.P. | 15,283 | $35,000 | 0.04% |
| CLOUGH CAPITAL PARTNERS L P | 136,228 | $316,000 | 0.04% |
| Tower Research Capital LLC (TRC) | 12,183 | $29,000 | 0.00% |
| Assenagon Asset Management S.A. | 69,931 | $162,000 | 0.00% |
| Ballentine Partners, LLC | 16,700 | $39,000 | 0.00% |
| A.R.T. Advisors, LLC | 10,206 | $24,000 | 0.00% |